listmodes analysis software winlist version 8.0 (Verity Software House)
90
Structured Review
Verity Software House
listmodes analysis software winlist version 8.0
Listmodes Analysis Software Winlist Version 8.0, supplied by Verity Software House, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/winlist+analysis+software/listmodes+analysis+software+winlist+version+8+0/pmc08528832-72-4-7
Average 90 stars, based on 1 article reviews
Listmodes Analysis Software Winlist Version 8.0, supplied by Verity Software House, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/winlist+analysis+software/listmodes+analysis+software+winlist+version+8+0/pmc08528832-72-4-7
Average 90 stars, based on 1 article reviews
listmodes analysis software winlist version 8.0 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: Survival of Allogeneic Self-Assembled Cultured Skin Article Snippet: .. Data were acquired using BectonDickinson FACScan (San Jose, CA) and analyzed with Article Title: Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4) Article Snippet: Flow cytometry data were analyzed using Winlist analysis software (Verity Software House, Topsham, Me.). .. Flow cytometry data were analyzed using Article Title: CD56brightnatural killer cells and response to daclizumab HYP in relapsing-remitting MS Article Snippet: .. Analyses were performed using Article Title: Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer. Article Snippet: Castration-resistant prostate cancer (CRPC) emerges after androgen withdrawal therapy and remains incurable due to the lack of effective treatment protocols.. Treatment with enzalutamide, a second generation androgen receptor (AR) antagonist, offers an initial response followed by drug resistance and tumor relapse.. Enhancer of zeste homolog 2 (EZH2), a member of PRC2 complex, is an important target that acts as a coactivator of ARmediated gene suppression whose oncogenic activity increases during castration. Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Cells were then incubated at 37 °C with 20 μ g/ml RNase A in 1 × PBS for 30 min, stained with 50 μ g/ml PI for 30 min, and analyzed using an Epics XL cytometer (Beckman Coulter, Miami, FL, USA), EXPO32 acquisition software (version 12, Verity Software House Inc., Topsham, ME, USA), and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Briefly, C4-2B cells were serum-starved overnight, treated with 4 μ M SIM and/or 2 mM MET for 48−96 h, trypsinized, washed with 1 × PBS, and 1 × 10 6 cells incubated and stained with AV and PI, and analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Article Title: SURVIVAL OF ALLOGENEIC SELF-ASSEMBLED CULTURED SKIN Article Snippet: .. Data were acquired using Becton–Dickinson FACScan (San Jose, CA, USA) and analyzed with Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. For quantization of percentage of AVO-positive cells, red (620 BP, FL3 channel, where BP=band pass) and green (525 BP, FL1 channel) fluorescence emissions from 3 × 10 4 cells from samples and control specimens illuminated with blue (488nm) excitation light was analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Flow Cytometry:Article Title: Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4) Article Snippet: Flow cytometry data were analyzed using Winlist analysis software (Verity Software House, Topsham, Me.). .. Flow cytometry data were analyzed using Cytometry:Article Title: Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer. Article Snippet: Castration-resistant prostate cancer (CRPC) emerges after androgen withdrawal therapy and remains incurable due to the lack of effective treatment protocols.. Treatment with enzalutamide, a second generation androgen receptor (AR) antagonist, offers an initial response followed by drug resistance and tumor relapse.. Enhancer of zeste homolog 2 (EZH2), a member of PRC2 complex, is an important target that acts as a coactivator of ARmediated gene suppression whose oncogenic activity increases during castration. Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Cells were then incubated at 37 °C with 20 μ g/ml RNase A in 1 × PBS for 30 min, stained with 50 μ g/ml PI for 30 min, and analyzed using an Epics XL cytometer (Beckman Coulter, Miami, FL, USA), EXPO32 acquisition software (version 12, Verity Software House Inc., Topsham, ME, USA), and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Briefly, C4-2B cells were serum-starved overnight, treated with 4 μ M SIM and/or 2 mM MET for 48−96 h, trypsinized, washed with 1 × PBS, and 1 × 10 6 cells incubated and stained with AV and PI, and analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. For quantization of percentage of AVO-positive cells, red (620 BP, FL3 channel, where BP=band pass) and green (525 BP, FL1 channel) fluorescence emissions from 3 × 10 4 cells from samples and control specimens illuminated with blue (488nm) excitation light was analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Incubation:Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Cells were then incubated at 37 °C with 20 μ g/ml RNase A in 1 × PBS for 30 min, stained with 50 μ g/ml PI for 30 min, and analyzed using an Epics XL cytometer (Beckman Coulter, Miami, FL, USA), EXPO32 acquisition software (version 12, Verity Software House Inc., Topsham, ME, USA), and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Briefly, C4-2B cells were serum-starved overnight, treated with 4 μ M SIM and/or 2 mM MET for 48−96 h, trypsinized, washed with 1 × PBS, and 1 × 10 6 cells incubated and stained with AV and PI, and analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Staining:Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Cells were then incubated at 37 °C with 20 μ g/ml RNase A in 1 × PBS for 30 min, stained with 50 μ g/ml PI for 30 min, and analyzed using an Epics XL cytometer (Beckman Coulter, Miami, FL, USA), EXPO32 acquisition software (version 12, Verity Software House Inc., Topsham, ME, USA), and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Briefly, C4-2B cells were serum-starved overnight, treated with 4 μ M SIM and/or 2 mM MET for 48−96 h, trypsinized, washed with 1 × PBS, and 1 × 10 6 cells incubated and stained with AV and PI, and analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Analysis:Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Cells were then incubated at 37 °C with 20 μ g/ml RNase A in 1 × PBS for 30 min, stained with 50 μ g/ml PI for 30 min, and analyzed using an Epics XL cytometer (Beckman Coulter, Miami, FL, USA), EXPO32 acquisition software (version 12, Verity Software House Inc., Topsham, ME, USA), and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Briefly, C4-2B cells were serum-starved overnight, treated with 4 μ M SIM and/or 2 mM MET for 48−96 h, trypsinized, washed with 1 × PBS, and 1 × 10 6 cells incubated and stained with AV and PI, and analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. For quantization of percentage of AVO-positive cells, red (620 BP, FL3 channel, where BP=band pass) and green (525 BP, FL1 channel) fluorescence emissions from 3 × 10 4 cells from samples and control specimens illuminated with blue (488nm) excitation light was analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Control:Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. Briefly, C4-2B cells were serum-starved overnight, treated with 4 μ M SIM and/or 2 mM MET for 48−96 h, trypsinized, washed with 1 × PBS, and 1 × 10 6 cells incubated and stained with AV and PI, and analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. For quantization of percentage of AVO-positive cells, red (620 BP, FL3 channel, where BP=band pass) and green (525 BP, FL1 channel) fluorescence emissions from 3 × 10 4 cells from samples and control specimens illuminated with blue (488nm) excitation light was analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and Fluorescence:Article Title: Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Article Snippet: .. For quantization of percentage of AVO-positive cells, red (620 BP, FL3 channel, where BP=band pass) and green (525 BP, FL1 channel) fluorescence emissions from 3 × 10 4 cells from samples and control specimens illuminated with blue (488nm) excitation light was analyzed using an Epics XL cytometer (Beckman Coulter), EXPO32 acquisition software, and |